Shuang‐Jian Qiu

机构：Sun Yat-sen University, Fudan University, Fudan University Shanghai Cancer Center, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University, Ministry of Education · ORCID：0000-0003-0097-3569

发表论文 56 篇 · 总被引 4526 次 · h-index 26

代表论文

• MAIT cells confer resistance to Lenvatinib plus anti-PD1 antibodies in hepatocellular carcinoma through TNF-TNFRSF1B pathway (2023 · Clinical Immunology · 被引 25)
• Down‐regulation of EOMES drives T‐cell exhaustion via abolishing EOMES‐mediated repression of inhibitory receptors of T cells in liver cancer (2020 · Journal of Cellular and Molecular Medicine · 被引 22)
• Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study (2025 · The Lancet Oncology · 被引 20)
• Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score‐matched survival analysis (2019 · Cancer Medicine · 被引 18)
• Tfr-Tfh index: A new predicator for recurrence of hepatocellular carcinoma patients with HBV infection after curative resection (2020 · Clinica Chimica Acta · 被引 10)
• Clinical significance of herpes virus entry mediator expression in hepatitis B virus‑related hepatocellular carcinoma (2020 · Oncology Letters · 被引 9)